Urodynamic stress incontinence, utero-vaginal prolapse Urological and Genital Diseases Other disorders of urinary system
Conditions
Interventions
All women electively admitted for surgery for urodynamic stress incontinence or pelvic organ prolapse were approached with a view to randomisation. A trial information leaflet was provided and those a
Sponsors
Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: All women electively admitted for surgery for urodynamic stress incontinence or pelvic organ prolapse. No age limits.
Exclusion criteria
Exclusion criteria: 1. Women undergoing surgery where post-operative catheterisation is not routinely employed 2. Women requiring continuous post-operative bladder drainage, e.g. following repair of vesico-vaginal fistula, urethral diverticulectomy, augmentation cystoplasty and operative bladder injury
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of hospital stay, measured from day of admission to day of discharge with a range of between 2 - 19 days. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The time to resume normal voiding (defined as voided volumes greater than 200 ml and post-void residual volumes consistently less than 100 ml), recorded within the time of the hospital stay 2. The number of episodes of urinary tract infection (UTI) (defined by catheter-specimen urine [CSU] or mid-stream urine [MSU] showing a single bacterium growing at a colony count greater than 100,000 colony forming units per ml), recorded within the time of the hospital stay 3. Patient experience of catheterisation as determined from a questionnaire given to patients at the end of their hospital stay, recorded within the time of the hospital stay, prior to discharge | — |
Countries
United Kingdom
Outcome results
None listed